Our esteemed panel will discuss their findings from Morningstar's latest research paper, Biopharma ESG Risks from U.S. Pricing doesn't sway our valuation.
Compliance consulting and mutual fund distribution company Foreside, which itself has grown significantly through acquisition over the last two and a half years, has been acquired by private equity firm Genstar Capital.